Meghan Brennan
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Breast Cancer Treatment Studies, Lung Cancer Treatments and Mutations, Breast Lesions and Carcinomas, DNA Repair Mechanisms
Most-Cited Works
- → Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial(2020)216 cited
- → Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression(2002)82 cited
- → Evaluation of axillary lymphadenectomy without axillary drainage for patients undergoing breast-conserving therapy(1998)54 cited
- → Sentinel node biopsy in breast cancer11No competing interests declared.(1999)52 cited
- → Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer(2018)43 cited
- → Meta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics(2011)40 cited
- → Does Sentinel Lymphadenectomy Improve Staging and Alter Therapy in Elderly Women With Breast Cancer?(2000)36 cited
- → Population pharmacokinetic analysis of axitinib in healthy volunteers(2013)28 cited
- → Non–small cell lung cancer clinical trials requiring biopsies with biomarker‐specific results for enrollment provide unique challenges(2017)23 cited
- → Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers(2015)22 cited